Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:29681787

The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature.

Anaïs Chauvin · Chang-Shu Wang · Sameh Geha · Perrine Garde-Granger · Alex-Ane Mathieu · Vincent Lacasse · François-Michel Boisvert

Clinical proteomics · 2018 doi:10.1186/s12014-018-9192-2

Paper

complete

Experiment

complete

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:29681787
kind
science-record
content_hash
sha256:0ee26f58b9f8c7ae5b6e2e7f4a63b781e947ce4a85076ff7f1f8a6e8e2b94b5b
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:40:33Z
updated_at
2026-11-01T22:43:21Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature.
doi
10.1186/s12014-018-9192-2
pmid
29681787
authors array · 7 items
[0]
Anaïs Chauvin
[1]
Chang-Shu Wang
[2]
Sameh Geha
[3]
Perrine Garde-Granger
[4]
Alex-Ane Mathieu
[5]
Vincent Lacasse
[6]
François-Michel Boisvert
journal
Clinical proteomics
year
2018
abstract
BACKGROUND: Colorectal cancer is the third most common and the fourth most lethal cancer in the world. In the majority of cases, patients are diagnosed at an advanced stage or even metastatic, thus explaining the high mortality. The standard treatment for patients with locally advanced non-metastatic rectal cancer is neoadjuvant radio-chemotherapy (NRCT) with 5-fluorouracil (5-FU) followed by surgery, but the resistance rate to this treatment remains high with approximately 30% of non-responders. The lack of evidence available in clinical practice to predict NRCT resistance to 5-FU and to guide clinical practice therefore encourages the search for biomarkers of this resistance. METHODS: From twenty-three formalin-fixed paraffin-embedded (FFPE) biopsies performed before NRCT with 5-FU of locally advanced non-metastatic rectal cancer patients, we extracted and analysed the tumor proteome of these patients. From clinical data, we were able to classify the twenty-three patients in our cohort into three treatment response groups: non-responders (NR), partial responders (PR) and total responders (TR), and to compare the proteomes of these different groups. RESULTS: We have highlighted 384 differentially abundant proteins between NR and PR, 248 between NR and TR and 417 between PR and TR. Among these proteins, we have identified many differentially abundant proteins identified as having a role in cancer (IFIT1, FASTKD2, PIP4K2B, ARID1B, SLC25A33: overexpressed in TR; CALD1, CPA3, B3GALT5, CD177, RIPK1: overexpressed in NR). We have also identified that DPYD, the main degradation enzyme of 5-FU, was overexpressed in NR, as well as several ribosomal and mitochondrial proteins also overexpressed in NR. Data are available via ProteomeXchange with identifier PXD008440. CONCLUSIONS: From these retrospective study, we implemented a protein extraction protocol from FFPE biopsy to highlight protein differences between different response groups to RCTN with 5-FU in patients with locally advanced non-metastatic rectal cancer. These results will pave the way for a larger cohort for better sensitivity and specificity of the signature to guide decisions in the choice of treatment.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
Finally, the analysis of mass spectrometry data were next carried out with the Perseus software package [19] and subjected to a normalization (z-score) and an ANOVA statistical test (comparison of the three groups) or Student’s T test (comparison of two groups), both corrected with a p value of 0.05.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:29681787
locator
sections[13] "Quantification and bioinformatics analysis" paragraph 2
quote
Finally, the analysis of mass spectrometry data were next carried out with the Perseus software package [19] and subjected to a normalization (z-score) and an ANOVA statistical test (comparison of the three groups) or Student’s T test (comparison of two groups), both corrected with a p value of 0.05.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:29681787
locator
sections[26] "ack" paragraph 1
quote
All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
The paper highlighted 384 differentially abundant proteins between non-responders and partial responders, using ANOVA and Student’s T test for statistical comparisons, and deposited the source proteomics data in ProteomeXchange under identifier PXD008440.
kind
quantitative
target object · 4 fields
value
0.05
unit
p-value
tolerance
null
source
Statistical tests used for these analyses are ANOVA test (1) and Student’s T test (2) both corrected with a p value of 0.05.
evidence array · 3 items
[0] object · 3 fields
asset
source:pmid:29681787
locator
sections[0] "Abstract" paragraph 3
quote
We have highlighted 384 differentially abundant proteins between NR and PR, 248 between NR and TR and 417 between PR and TR.
[1] object · 3 fields
asset
source:pmid:29681787
locator
sections[19] "Identification of differentially abundant proteins between groups" paragraph 3
quote
Statistical tests used for these analyses are ANOVA test (1) and Student’s T test (2) both corrected with a p value of 0.05.
[2] object · 3 fields
asset
source:pmid:29681787
locator
sections[0] "Abstract" paragraph 3
quote
Data are available via ProteomeXchange with identifier PXD008440.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
The paper highlighted 384 differentially abundant proteins between non-responders and partial responders, using ANOVA and Student’s T test for statistical comparisons, and deposited the source proteomics data in ProteomeXchange under identifier PXD008440.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:29681787
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD008440
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 1 field
p_value
, both corrected with a p value of 0
inputs array · 1 item
[0]
data:geo:PXD008440
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 6 items
[0] object · 15 fields
id
source:pmid:29681787
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1186/s12014-018-9192-2
sha256
sha256:75275a7d036c6c519b66605147a8a5c48fd56a9a13457c9b81305d26f0a5903a
bytes
51777
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1186/s12014-018-9192-2
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC5898006
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:PXD008440
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD008440
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
PXD008440
version
null
note
All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440.
access_statement_kind
data_availability_statement
sample_accessions array · 0 items
sample_count
null
group_sizes
null
group_sizes_basis
null
platform
null
taxon
null
title
The response to neoadjuvant chemoradiotherapy to 5-fluorouracil in locally advanced colorectal cancer patients: a predictive proteomic signature.
resolution_checked_at
2026-10-31T18:35:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 16 fields
id
asset:table:pmid:29681787:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:68526178f158fa1a73fac12b97c5bcf1740f4c6fb9c80c26dfcb0f8e840269dc
bytes
1462
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[3]/table-wrap[1]#Tab1
version
null
note
Baseline patient characteristics
structure object · 5 fields
pmcid
PMC5898006
section_index
3
section_title
Study design and clinical protocol
row_count
27
column_count
6
table object · 8 fields
label
Table 1
caption
Baseline patient characteristics
rows array · 27 items
[0] array · 6 items
[0]
Characteristics
[1]
All patients23 (100)a
[2]
NR7 (30)
[3]
PR10 (43)
[4]
TR6 (26)
[5]
p valueb
[1] array · 6 items
[0]
Age (years)
[1]
[2]
[3]
[4]
[5]
[2] array · 6 items
[0]
Median
[1]
58.6 ± 11.1
[2]
54.7 ± 14.3
[3]
59.7 ± 10.2
[4]
61.3 ± 8.6
[5]
[3] array · 6 items
[0]
Range
[1]
31–75
[2]
31–72
[3]
47–75
[4]
48–71
[5]
[4] array · 6 items
[0]
Sex
[1]
[2]
[3]
[4]
[5]
0.324
[5] array · 6 items
[0]
Male
[1]
19 (83)
[2]
7 (100)
[3]
7 (70)
[4]
5 (83)
[5]
[6] array · 6 items
[0]
Female
[1]
4 (17)
[2]
0
[3]
3 (30)
[4]
1 (17)
[5]
[7] array · 6 items
[0]
Tumor location from anal verge (cm)
[1]
[2]
[3]
[4]
[5]
0.961
[8] array · 6 items
[0]
3–5
[1]
10 (43)
[2]
3 (43)
[3]
5 (50)
[4]
2 (33)
[5]
[9] array · 6 items
[0]
6–10
[1]
11 (48)
[2]
3 (43)
[3]
4 (40)
[4]
4 (67)
[5]
[10] array · 6 items
[0]
> 10
[1]
2 (9)
[2]
1 (14)
[3]
1 (10)
[4]
0
[5]
[11] array · 6 items
[0]
Tumor differentiation
[1]
[2]
[3]
[4]
[5]
0.884
[12] array · 6 items
[0]
Missing value
[1]
9 (39)
[2]
3 (43)
[3]
3 (30)
[4]
3 (50)
[5]
[13] array · 6 items
[0]
Well
[1]
5 (22)
[2]
2 (29)
[3]
2 (20)
[4]
1 (17)
[5]
[14] array · 6 items
[0]
Moderately
[1]
9 (39)
[2]
2 (29)
[3]
5 (50)
[4]
2 (33)
[5]
[15] array · 6 items
[0]
Undifferentiated
[1]
0
[2]
0
[3]
0
[4]
0
[5]
[16] array · 6 items
[0]
Pre-treatment stage
[1]
[2]
[3]
[4]
[5]
0.441
[17] array · 6 items
[0]
IIA
[1]
3 (13)
[2]
0
[3]
2 (20)
[4]
1 (17)
[5]
[18] array · 6 items
[0]
IIIA
[1]
1 (4)
[2]
0
[3]
1 (10)
[4]
0
[5]
[19] array · 6 items
[0]
IIIA–IIIB
[1]
2 (9)
[2]
0
[3]
0
[4]
2 (33)
[5]
[20] array · 6 items
[0]
IIIB
[1]
4 (17)
[2]
1 (14)
[3]
2 (20)
[4]
1 (17)
[5]
[21] array · 6 items
[0]
IIIB–IIIC
[1]
12 (52)
[2]
5 (71)
[3]
5 (50)
[4]
2 (33)
[5]
[22] array · 6 items
[0]
IIIC
[1]
1 (4)
[2]
1 (14)
[3]
0
[4]
0
[5]
[23] array · 6 items
[0]
iT
[1]
[2]
[3]
[4]
[5]
0.560
[24] array · 6 items
[0]
T2
[1]
3 (13)
[2]
0
[3]
1 (10)
[4]
2 (33)
[5]
[25] array · 6 items
[0]
T3
[1]
18 (78)
[2]
6 (86)
[3]
8 (80)
[4]
4 (67)
[5]
[26] array · 6 items
[0]
T4
[1]
2 (9)
[2]
1 (14)
[3]
1 (10)
[4]
0
[5]
locator
section[3]/table-wrap[1]#Tab1
[3] object · 16 fields
id
asset:table:pmid:29681787:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:039fbae5bd86cb235ff2fbf6c907d0b5f642a8fd87906283c36ab717b9029cca
bytes
1520
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[17]/table-wrap[1]#Tab2
version
null
note
Surgical treatment and complications
structure object · 5 fields
pmcid
PMC5898006
section_index
17
section_title
Surgical treatment and complications
row_count
29
column_count
6
table object · 8 fields
label
Table 2
caption
Surgical treatment and complications
rows array · 29 items
[0] array · 6 items
[0]
Characteristics
[1]
All patients23 (100%)a
[2]
NR7 (30%)
[3]
PR10 (43%)
[4]
TR6 (26%)
[5]
p valueb
[1] array · 6 items
[0]
Radiotherapy
[1]
[2]
[3]
[4]
[5]
0.822
[2] array · 6 items
[0]
45 Gy
[1]
1 (4)
[2]
0
[3]
1 (10)
[4]
0
[5]
[3] array · 6 items
[0]
45 Gy + 5.4 Gy
[1]
21 (91)
[2]
6 (86)
[3]
9 (90)
[4]
6 (100)
[5]
[4] array · 6 items
[0]
50.5 Gy
[1]
1 (4)
[2]
1 (14)
[3]
0
[4]
0
[5]
[5] array · 6 items
[0]
Chemotherapy
[1]
[2]
[3]
[4]
[5]
3.2e−05
[6] array · 6 items
[0]
Xeloda®
[1]
22 (96)
[2]
7 (100)
[3]
9 (90)
[4]
6 (100)
[5]
[7] array · 6 items
[0]
5-FU
[1]
1 (4)
[2]
0
[3]
1 (10)
[4]
0
[5]
[8] array · 6 items
[0]
Radiodermatitis
[1]
[2]
[3]
[4]
[5]
0.962
[9] array · 6 items
[0]
−
[1]
7 (30)
[2]
2 (29)
[3]
3 (30)
[4]
2 (33)
[5]
[10] array · 6 items
[0]
Non-severe
[1]
13 (57)
[2]
4 (57)
[3]
5 (50)
[4]
4 (67)
[5]
[11] array · 6 items
[0]
Severe
[1]
3 (13)
[2]
1 (14)
[3]
2 (20)
[4]
0
[5]
[12] array · 6 items
[0]
Proctitis
[1]
[2]
[3]
[4]
[5]
0.211
[13] array · 6 items
[0]
+
[1]
11 (48)
[2]
2 (29)
[3]
7 (70)
[4]
2 (33)
[5]
[14] array · 6 items
[0]
−
[1]
12 (52)
[2]
5 (71)
[3]
3 (30)
[4]
4 (67)
[5]
[15] array · 6 items
[0]
Colitis
[1]
[2]
[3]
[4]
[5]
1
[16] array · 6 items
[0]
+
[1]
0
[2]
0
[3]
0
[4]
0
[5]
[17] array · 6 items
[0]
−
[1]
23 (100)
[2]
7 (100)
[3]
10 (100)
[4]
6 (100)
[5]
[18] array · 6 items
[0]
Mucositis
[1]
[2]
[3]
[4]
[5]
1
[19] array · 6 items
[0]
+
[1]
0
[2]
0
[3]
0
[4]
0
[5]
[20] array · 6 items
[0]
−
[1]
23 (100)
[2]
7 (100)
[3]
10 (100)
[4]
6 (100)
[5]
[21] array · 6 items
[0]
Surgical resection type
[1]
[2]
[3]
[4]
[5]
0.004
[22] array · 6 items
[0]
Low anterior
[1]
17 (74)
[2]
7 (100)
[3]
8 (80)
[4]
2 (33)
[5]
[23] array · 6 items
[0]
Abdomino-perineal
[1]
2 (9)
[2]
0
[3]
2 (20)
[4]
0
[5]
[24] array · 6 items
[0]
Endo-anal
[1]
1 (4)
[2]
0
[3]
0
[4]
1 (17)
[5]
[25] array · 6 items
[0]
Refused
[1]
3 (13)
[2]
0
[3]
0
[4]
3 (50)
[5]
[26] array · 6 items
[0]
Surgery delay
[1]
[2]
[3]
[4]
[5]
[27] array · 6 items
[0]
Median
[1]
8.6 ± 2.8
[2]
9.3 ± 2.7
[3]
8.3 ± 3.1
[4]
8.1 ± 2.6
[5]
[28] array · 6 items
[0]
Range
[1]
1.4–13.1
[2]
5.3–13.1
[3]
1.4–12.9
[4]
6.0–11.0
[5]
locator
section[17]/table-wrap[1]#Tab2
[4] object · 16 fields
id
asset:table:pmid:29681787:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:17e17bd057aafd7a6687321e931f8b5d7cb34e8bc78e0e633bd25d8365c8f272
bytes
1312
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[18]/table-wrap[1]#Tab3
version
null
note
Post-treatment patient characteristics
structure object · 5 fields
pmcid
PMC5898006
section_index
18
section_title
Neoadjuvant chemoradiotherapy post-treatment results
row_count
26
column_count
6
table object · 8 fields
label
Table 3
caption
Post-treatment patient characteristics
rows array · 26 items
[0] array · 6 items
[0]
Characteristics
[1]
All patients 23 (100%)a
[2]
NR 7 (30%)
[3]
PR 10 (43%)
[4]
TR 6 (26%)
[5]
p valueb
[1] array · 6 items
[0]
Tumor diff. after treatment
[1]
[2]
[3]
[4]
[5]
0.064
[2] array · 6 items
[0]
No surgery
[1]
3 (13)
[2]
0
[3]
0
[4]
3 (50)
[5]
[3] array · 6 items
[0]
Missing value
[1]
5 (22)
[2]
2 (29)
[3]
1 (10)
[4]
2 (33)
[5]
[4] array · 6 items
[0]
Well
[1]
5 (22)
[2]
1 (14)
[3]
4 (40)
[4]
0
[5]
[5] array · 6 items
[0]
Moderately
[1]
9 (39)
[2]
3 (43)
[3]
5 (50)
[4]
1 (17)
[5]
[6] array · 6 items
[0]
Undifferentiated
[1]
1 (4)
[2]
1 (14)
[3]
0
[4]
0
[5]
[7] array · 6 items
[0]
Post-treatment stage
[1]
[2]
[3]
[4]
[5]
3.3e−08
[8] array · 6 items
[0]
0
[1]
6 (26)
[2]
0
[3]
0
[4]
6 (100)
[5]
[9] array · 6 items
[0]
I
[1]
7 (30)
[2]
0
[3]
7 (70)
[4]
0
[5]
[10] array · 6 items
[0]
IIA
[1]
3 (13)
[2]
2 (29)
[3]
1 (10)
[4]
0
[5]
[11] array · 6 items
[0]
IIIA
[1]
2 (9)
[2]
0
[3]
2 (20)
[4]
0
[5]
[12] array · 6 items
[0]
IIIB
[1]
2 (9)
[2]
2 (29)
[3]
0
[4]
0
[5]
[13] array · 6 items
[0]
IIIB–IIIC
[1]
3 (13)
[2]
3 (43)
[3]
0
[4]
0
[5]
[14] array · 6 items
[0]
ypT
[1]
[2]
[3]
[4]
[5]
4.6e−08
[15] array · 6 items
[0]
T0
[1]
6 (26)
[2]
0
[3]
0
[4]
6 (100)
[5]
[16] array · 6 items
[0]
T1
[1]
3 (13)
[2]
0
[3]
3 (30)
[4]
0
[5]
[17] array · 6 items
[0]
T2
[1]
6 (26)
[2]
0
[3]
6 (60)
[4]
0
[5]
[18] array · 6 items
[0]
T3
[1]
7 (30)
[2]
6 (86)
[3]
1 (10)
[4]
0
[5]
[19] array · 6 items
[0]
T4
[1]
1 (4)
[2]
1 (14)
[3]
0
[4]
0
[5]
[20] array · 6 items
[0]
PNI
[1]
[2]
[3]
[4]
[5]
1
[21] array · 6 items
[0]
+
[1]
2 (9)
[2]
1 (14)
[3]
1 (10)
[4]
0
[5]
[22] array · 6 items
[0]
−
[1]
21 (91)
[2]
6 (86)
[3]
9 (90)
[4]
6 (100)
[5]
[23] array · 6 items
[0]
LVI
[1]
[2]
[3]
[4]
[5]
0.002
[24] array · 6 items
[0]
+
[1]
8 (35)
[2]
6 (86)
[3]
2 (20)
[4]
0
[5]
[25] array · 6 items
[0]
−
[1]
15 (65)
[2]
1 (14)
[3]
8 (80)
[4]
6 (100)
[5]
locator
section[18]/table-wrap[1]#Tab3
[5] object · 16 fields
id
asset:table:pmid:29681787:4
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:ee58fe6a84ea3505ccb78f22335b267edb0974965969b49c86b57ad486de896f
bytes
501
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[19]/table-wrap[1]#Tab4
version
null
note
Numbers of differentially abundant proteins between each group of responders
structure object · 5 fields
pmcid
PMC5898006
section_index
19
section_title
Identification of differentially abundant proteins between groups
row_count
7
column_count
5
table object · 8 fields
label
Table 4
caption
Numbers of differentially abundant proteins between each group of responders
rows array · 7 items
[0] array · 5 items
[0]
[1]
Total
[2]
NR
[3]
PR
[4]
TR
[1] array · 5 items
[0]
NR versus PR versus TRa
[1]
402
[2]
[3]
[4]
[2] array · 5 items
[0]
NR versus PRb
[1]
384
[2]
180
[3]
204
[4]
[3] array · 5 items
[0]
NR versus TRb
[1]
248
[2]
139
[3]
[4]
109
[4] array · 5 items
[0]
PR versus TRb
[1]
417
[2]
[3]
294
[4]
123
[5] array · 5 items
[0]
NR versus PR + TRb
[1]
282
[2]
139
[3]
143
[4]
[6] array · 5 items
[0]
NR + PR versus TRb
[1]
368
[2]
93
[3]
275
[4]
locator
section[19]/table-wrap[1]#Tab4
gaps array · 2 items
[0]
asset:data:geo:PXD008440 not downloaded
[1]
asset:data:geo:PXD008440 licence not read
analysis object · 4 fields
state
complete
methods array · 1 item
[0] object · 10 fields
id
method-1
family
group_comparison
specific
anova
label
Group comparison
dsl_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
missing_operations array · 0 items
parameters object · 1 field
p_value
, both corrected with a p value of 0
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
1
band
verbatim
quote
Finally, the analysis of mass spectrometry data were next carried out with the Perseus software package [19] and subjected to a normalization (z-score) and an ANOVA statistical test (comparison of the three groups) or Student’s T test (comparison of two groups), both corrected with a p value of 0.05.
targets array · 1 item
[0] object · 8 fields
id
target-published-estimate
claim_id
claim-target-result
operation
bootstrap_mean_difference
unit
p-value
tolerance
null
state
complete
note
The threshold the paper applied to its own result, as the paper states it. A run that reproduces the effect is judged against this threshold.
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: anova.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
PXD008440
resolved_accessions array · 1 item
[0]
PXD008440
statements array · 1 item
[0]
All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440.
basis
The paper names PXD008440 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
assets array · 6 items
[0]
source:pmid:29681787
[1]
data:geo:PXD008440
[2]
asset:table:pmid:29681787:1
[3]
asset:table:pmid:29681787:2
[4]
asset:table:pmid:29681787:3
[5]
asset:table:pmid:29681787:4
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:PXD008440
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:34:24Z
independence
same_provider
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
8
usage object · 3 fields
prompt_tokens
108044
completion_tokens
3578
cached_tokens
1560
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:29681787
type
paper
label
pmid:29681787
[1] object · 3 fields
id
source:pmid:29681787
type
manuscript
label
PMID 29681787 full text
[2] object · 3 fields
id
data:geo:PXD008440
type
dataset
label
GEO PXD008440
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:29681787
type
paper
label
pmid:29681787
[1] object · 3 fields
id
source:pmid:29681787
type
manuscript
label
PMID 29681787 full text
[2] object · 3 fields
id
data:geo:PXD008440
type
dataset
label
GEO PXD008440
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-29681787
type
extraction
used array · 1 item
[0]
source:pmid:29681787
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-PXD008440
type
accession_resolution
used array · 1 item
[0]
data:geo:PXD008440
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:29681787
parent_hash
sha256:b2ff0fd46bd727ca4c5b476eb7f10e25795e2009efa80bd21c72c17105d872ea
fork_of
null
gaps array · 6 items
[0]
asset:data:geo:PXD008440 licence not read
[1]
asset:data:geo:PXD008440 not downloaded
[2]
execution.not_run
[3]
review.human_critique
[4]
review.independent_reader
[5]
review.machine_critique
assays array · 2 items
[0] object · 11 fields
role
data_generation
definition_id
microarray
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 3 items
[0]
tial responders, RT radiotherapy, TMA tissue microarray, TR total responders Table 1Baseline patient
[1]
the paraffin blocks (Fig. 2b) using a Tissue Microarray (TMA) Master II (3DHISTECH) (Fig. 1b).Fig. 2
[2]
formalin-fixed paraffin-embedded, TMA tissue microarray Statistical analysis The different groups of
order_basis
paper_text_order:6711
id
assay:1
[1] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Finally, the analysis of mass spectrometry data were next carried out with the Perseus software package [19] and subjected to a normalization (z-score) and an ANOVA statistical test (comparison of the three groups) or Student’s T test (comparison of two groups), both corrected with a p value of 0.05.
order_basis
consumes_earlier_output
id
assay:2
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:29681787", "kind": "science-record", "revision": 8, "content_hash": "sha256:0ee26f58b9f8c7ae5b6e2e7f4a63b781e947ce4a85076ff7f1f8a6e8e2b94b5b", "created_at": "2026-11-01T15:40:33Z", "updated_at": "2026-11-01T22:43:21Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature.", "doi": "10.1186/s12014-018-9192-2", "pmid": "29681787", "authors": ["Anaïs Chauvin", "Chang-Shu Wang", "Sameh Geha", "Perrine Garde-Granger", "Alex-Ane Mathieu", "Vincent Lacasse", "François-Michel Boisvert"], "journal": "Clinical proteomics", "year": 2018, "abstract": "BACKGROUND: Colorectal cancer is the third most common and the fourth most lethal cancer in the world. In the majority of cases, patients are diagnosed at an advanced stage or even metastatic, thus explaining the high mortality. The standard treatment for patients with locally advanced non-metastatic rectal cancer is neoadjuvant radio-chemotherapy (NRCT) with 5-fluorouracil (5-FU) followed by surgery, but the resistance rate to this treatment remains high with approximately 30% of non-responders. The lack of evidence available in clinical practice to predict NRCT resistance to 5-FU and to guide clinical practice therefore encourages the search for biomarkers of this resistance.\nMETHODS: From twenty-three formalin-fixed paraffin-embedded (FFPE) biopsies performed before NRCT with 5-FU of locally advanced non-metastatic rectal cancer patients, we extracted and analysed the tumor proteome of these patients. From clinical data, we were able to classify the twenty-three patients in our cohort into three treatment response groups: non-responders (NR), partial responders (PR) and total responders (TR), and to compare the proteomes of these different groups.\nRESULTS: We have highlighted 384 differentially abundant proteins between NR and PR, 248 between NR and TR and 417 between PR and TR. Among these proteins, we have identified many differentially abundant proteins identified as having a role in cancer (IFIT1, FASTKD2, PIP4K2B, ARID1B, SLC25A33: overexpressed in TR; CALD1, CPA3, B3GALT5, CD177, RIPK1: overexpressed in NR). We have also identified that DPYD, the main degradation enzyme of 5-FU, was overexpressed in NR, as well as several ribosomal and mitochondrial proteins also overexpressed in NR. Data are available via ProteomeXchange with identifier PXD008440.\nCONCLUSIONS: From these retrospective study, we implemented a protein extraction protocol from FFPE biopsy to highlight protein differences between different response groups to RCTN with 5-FU in patients with locally advanced non-metastatic rectal cancer. These results will pave the way for a larger cohort for better sensitivity and specificity of the signature to guide decisions in the choice of treatment.", "claims": [{"id": "claim-method", "statement": "Finally, the analysis of mass spectrometry data were next carried out with the Perseus software package [19] and subjected to a normalization (z-score) and an ANOVA statistical test (comparison of the three groups) or Student’s T test (comparison of two groups), both corrected with a p value of 0.05.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:29681787", "locator": "sections[13] \"Quantification and bioinformatics analysis\" paragraph 2", "quote": "Finally, the analysis of mass spectrometry data were next carried out with the Perseus software package [19] and subjected to a normalization (z-score) and an ANOVA statistical test (comparison of the three groups) or Student’s T test (comparison of two groups), both corrected with a p value of 0.05."}], "state": "complete"}, {"id": "claim-data-access", "statement": "All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:29681787", "locator": "sections[26] \"ack\" paragraph 1", "quote": "All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440."}], "state": "complete"}, {"id": "claim-target-result", "statement": "The paper highlighted 384 differentially abundant proteins between non-responders and partial responders, using ANOVA and Student’s T test for statistical comparisons, and deposited the source proteomics data in ProteomeXchange under identifier PXD008440.", "kind": "quantitative", "target": {"value": 0.05, "unit": "p-value", "tolerance": null, "source": "Statistical tests used for these analyses are ANOVA test (1) and Student’s T test (2) both corrected with a p value of 0.05."}, "evidence": [{"asset": "source:pmid:29681787", "locator": "sections[0] \"Abstract\" paragraph 3", "quote": "We have highlighted 384 differentially abundant proteins between NR and PR, 248 between NR and TR and 417 between PR and TR."}, {"asset": "source:pmid:29681787", "locator": "sections[19] \"Identification of differentially abundant proteins between groups\" paragraph 3", "quote": "Statistical tests used for these analyses are ANOVA test (1) and Student’s T test (2) both corrected with a p value of 0.05."}, {"asset": "source:pmid:29681787", "locator": "sections[0] \"Abstract\" paragraph 3", "quote": "Data are available via ProteomeXchange with identifier PXD008440."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "The paper highlighted 384 differentially abundant proteins between non-responders and partial responders, using ANOVA and Student’s T test for statistical comparisons, and deposited the source proteomics data in ProteomeXchange under identifier PXD008440.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:29681787"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD008440"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {"p_value": ", both corrected with a p value of 0"}, "inputs": ["data:geo:PXD008440"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:29681787", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1186/s12014-018-9192-2", "sha256": "sha256:75275a7d036c6c519b66605147a8a5c48fd56a9a13457c9b81305d26f0a5903a", "bytes": 51777, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1186/s12014-018-9192-2", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC5898006", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD008440", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD008440", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD008440", "version": null, "note": "All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": "The response to neoadjuvant chemoradiotherapy to 5-fluorouracil in locally advanced colorectal cancer patients: a predictive proteomic signature.", "resolution_checked_at": "2026-10-31T18:35:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:29681787:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:68526178f158fa1a73fac12b97c5bcf1740f4c6fb9c80c26dfcb0f8e840269dc", "bytes": 1462, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[3]/table-wrap[1]#Tab1", "version": null, "note": "Baseline patient characteristics", "structure": {"pmcid": "PMC5898006", "section_index": 3, "section_title": "Study design and clinical protocol", "row_count": 27, "column_count": 6}, "table": {"label": "Table 1", "caption": "Baseline patient characteristics", "rows": [["Characteristics", "All patients23 (100)a", "NR7 (30)", "PR10 (43)", "TR6 (26)", "p valueb"], ["Age (years)", "", "", "", "", ""], ["Median", "58.6 ± 11.1", "54.7 ± 14.3", "59.7 ± 10.2", "61.3 ± 8.6", ""], ["Range", "31–75", "31–72", "47–75", "48–71", ""], ["Sex", "", "", "", "", "0.324"], ["Male", "19 (83)", "7 (100)", "7 (70)", "5 (83)", ""], ["Female", "4 (17)", "0", "3 (30)", "1 (17)", ""], ["Tumor location from anal verge (cm)", "", "", "", "", "0.961"], ["3–5", "10 (43)", "3 (43)", "5 (50)", "2 (33)", ""], ["6–10", "11 (48)", "3 (43)", "4 (40)", "4 (67)", ""], ["> 10", "2 (9)", "1 (14)", "1 (10)", "0", ""], ["Tumor differentiation", "", "", "", "", "0.884"], ["Missing value", "9 (39)", "3 (43)", "3 (30)", "3 (50)", ""], ["Well", "5 (22)", "2 (29)", "2 (20)", "1 (17)", ""], ["Moderately", "9 (39)", "2 (29)", "5 (50)", "2 (33)", ""], ["Undifferentiated", "0", "0", "0", "0", ""], ["Pre-treatment stage", "", "", "", "", "0.441"], ["IIA", "3 (13)", "0", "2 (20)", "1 (17)", ""], ["IIIA", "1 (4)", "0", "1 (10)", "0", ""], ["IIIA–IIIB", "2 (9)", "0", "0", "2 (33)", ""], ["IIIB", "4 (17)", "1 (14)", "2 (20)", "1 (17)", ""], ["IIIB–IIIC", "12 (52)", "5 (71)", "5 (50)", "2 (33)", ""], ["IIIC", "1 (4)", "1 (14)", "0", "0", ""], ["iT", "", "", "", "", "0.560"], ["T2", "3 (13)", "0", "1 (10)", "2 (33)", ""], ["T3", "18 (78)", "6 (86)", "8 (80)", "4 (67)", ""], ["T4", "2 (9)", "1 (14)", "1 (10)", "0", ""]], "row_count": 27, "column_count": 6, "numeric_cells": 92, "header_rows": 1, "locator": "section[3]/table-wrap[1]#Tab1"}}, {"id": "asset:table:pmid:29681787:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:039fbae5bd86cb235ff2fbf6c907d0b5f642a8fd87906283c36ab717b9029cca", "bytes": 1520, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[1]#Tab2", "version": null, "note": "Surgical treatment and complications", "structure": {"pmcid": "PMC5898006", "section_index": 17, "section_title": "Surgical treatment and complications", "row_count": 29, "column_count": 6}, "table": {"label": "Table 2", "caption": "Surgical treatment and complications", "rows": [["Characteristics", "All patients23 (100%)a", "NR7 (30%)", "PR10 (43%)", "TR6 (26%)", "p valueb"], ["Radiotherapy", "", "", "", "", "0.822"], ["45 Gy", "1 (4)", "0", "1 (10)", "0", ""], ["45 Gy + 5.4 Gy", "21 (91)", "6 (86)", "9 (90)", "6 (100)", ""], ["50.5 Gy", "1 (4)", "1 (14)", "0", "0", ""], ["Chemotherapy", "", "", "", "", "3.2e−05"], ["Xeloda®", "22 (96)", "7 (100)", "9 (90)", "6 (100)", ""], ["5-FU", "1 (4)", "0", "1 (10)", "0", ""], ["Radiodermatitis", "", "", "", "", "0.962"], ["−", "7 (30)", "2 (29)", "3 (30)", "2 (33)", ""], ["Non-severe", "13 (57)", "4 (57)", "5 (50)", "4 (67)", ""], ["Severe", "3 (13)", "1 (14)", "2 (20)", "0", ""], ["Proctitis", "", "", "", "", "0.211"], ["+", "11 (48)", "2 (29)", "7 (70)", "2 (33)", ""], ["−", "12 (52)", "5 (71)", "3 (30)", "4 (67)", ""], ["Colitis", "", "", "", "", "1"], ["+", "0", "0", "0", "0", ""], ["−", "23 (100)", "7 (100)", "10 (100)", "6 (100)", ""], ["Mucositis", "", "", "", "", "1"], ["+", "0", "0", "0", "0", ""], ["−", "23 (100)", "7 (100)", "10 (100)", "6 (100)", ""], ["Surgical resection type", "", "", "", "", "0.004"], ["Low anterior", "17 (74)", "7 (100)", "8 (80)", "2 (33)", ""], ["Abdomino-perineal", "2 (9)", "0", "2 (20)", "0", ""], ["Endo-anal", "1 (4)", "0", "0", "1 (17)", ""], ["Refused", "3 (13)", "0", "0", "3 (50)", ""], ["Surgery delay", "", "", "", "", ""], ["Median", "8.6 ± 2.8", "9.3 ± 2.7", "8.3 ± 3.1", "8.1 ± 2.6", ""], ["Range", "1.4–13.1", "5.3–13.1", "1.4–12.9", "6.0–11.0", ""]], "row_count": 29, "column_count": 6, "numeric_cells": 95, "header_rows": 1, "locator": "section[17]/table-wrap[1]#Tab2"}}, {"id": "asset:table:pmid:29681787:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:17e17bd057aafd7a6687321e931f8b5d7cb34e8bc78e0e633bd25d8365c8f272", "bytes": 1312, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[18]/table-wrap[1]#Tab3", "version": null, "note": "Post-treatment patient characteristics", "structure": {"pmcid": "PMC5898006", "section_index": 18, "section_title": "Neoadjuvant chemoradiotherapy post-treatment results", "row_count": 26, "column_count": 6}, "table": {"label": "Table 3", "caption": "Post-treatment patient characteristics", "rows": [["Characteristics", "All patients 23 (100%)a", "NR 7 (30%)", "PR 10 (43%)", "TR 6 (26%)", "p valueb"], ["Tumor diff. after treatment", "", "", "", "", "0.064"], ["No surgery", "3 (13)", "0", "0", "3 (50)", ""], ["Missing value", "5 (22)", "2 (29)", "1 (10)", "2 (33)", ""], ["Well", "5 (22)", "1 (14)", "4 (40)", "0", ""], ["Moderately", "9 (39)", "3 (43)", "5 (50)", "1 (17)", ""], ["Undifferentiated", "1 (4)", "1 (14)", "0", "0", ""], ["Post-treatment stage", "", "", "", "", "3.3e−08"], ["0", "6 (26)", "0", "0", "6 (100)", ""], ["I", "7 (30)", "0", "7 (70)", "0", ""], ["IIA", "3 (13)", "2 (29)", "1 (10)", "0", ""], ["IIIA", "2 (9)", "0", "2 (20)", "0", ""], ["IIIB", "2 (9)", "2 (29)", "0", "0", ""], ["IIIB–IIIC", "3 (13)", "3 (43)", "0", "0", ""], ["ypT", "", "", "", "", "4.6e−08"], ["T0", "6 (26)", "0", "0", "6 (100)", ""], ["T1", "3 (13)", "0", "3 (30)", "0", ""], ["T2", "6 (26)", "0", "6 (60)", "0", ""], ["T3", "7 (30)", "6 (86)", "1 (10)", "0", ""], ["T4", "1 (4)", "1 (14)", "0", "0", ""], ["PNI", "", "", "", "", "1"], ["+", "2 (9)", "1 (14)", "1 (10)", "0", ""], ["−", "21 (91)", "6 (86)", "9 (90)", "6 (100)", ""], ["LVI", "", "", "", "", "0.002"], ["+", "8 (35)", "6 (86)", "2 (20)", "0", ""], ["−", "15 (65)", "1 (14)", "8 (80)", "6 (100)", ""]], "row_count": 26, "column_count": 6, "numeric_cells": 90, "header_rows": 1, "locator": "section[18]/table-wrap[1]#Tab3"}}, {"id": "asset:table:pmid:29681787:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:ee58fe6a84ea3505ccb78f22335b267edb0974965969b49c86b57ad486de896f", "bytes": 501, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[19]/table-wrap[1]#Tab4", "version": null, "note": "Numbers of differentially abundant proteins between each group of responders", "structure": {"pmcid": "PMC5898006", "section_index": 19, "section_title": "Identification of differentially abundant proteins between groups", "row_count": 7, "column_count": 5}, "table": {"label": "Table 4", "caption": "Numbers of differentially abundant proteins between each group of responders", "rows": [["", "Total", "NR", "PR", "TR"], ["NR versus PR versus TRa", "402", "", "", ""], ["NR versus PRb", "384", "180", "204", ""], ["NR versus TRb", "248", "139", "", "109"], ["PR versus TRb", "417", "", "294", "123"], ["NR versus PR + TRb", "282", "139", "143", ""], ["NR + PR versus TRb", "368", "93", "275", ""]], "row_count": 7, "column_count": 5, "numeric_cells": 16, "header_rows": 1, "locator": "section[19]/table-wrap[1]#Tab4"}}], "gaps": ["asset:data:geo:PXD008440 not downloaded", "asset:data:geo:PXD008440 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "anova", "label": "Group comparison", "dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "expressible": true, "parameters": {"p_value": ", both corrected with a p value of 0"}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Finally, the analysis of mass spectrometry data were next carried out with the Perseus software package [19] and subjected to a normalization (z-score) and an ANOVA statistical test (comparison of the three groups) or Student’s T test (comparison of two groups), both corrected with a p value of 0.05."}}], "targets": [{"id": "target-published-estimate", "claim_id": "claim-target-result", "operation": "bootstrap_mean_difference", "expected_value": 0.05, "unit": "p-value", "tolerance": null, "state": "complete", "note": "The threshold the paper applied to its own result, as the paper states it. A run that reproduces the effect is judged against this threshold."}], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: anova."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["PXD008440"], "resolved_accessions": ["PXD008440"], "statements": ["All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440."], "basis": "The paper names PXD008440 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "assets": ["source:pmid:29681787", "data:geo:PXD008440", "asset:table:pmid:29681787:1", "asset:table:pmid:29681787:2", "asset:table:pmid:29681787:3", "asset:table:pmid:29681787:4"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD008440"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:34:24Z", "independence": "same_provider"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 8, "usage": {"prompt_tokens": 108044, "completion_tokens": 3578, "cached_tokens": 1560}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:29681787", "type": "paper", "label": "pmid:29681787"}, {"id": "source:pmid:29681787", "type": "manuscript", "label": "PMID 29681787 full text"}, {"id": "data:geo:PXD008440", "type": "dataset", "label": "GEO PXD008440"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:29681787", "type": "paper", "label": "pmid:29681787"}, {"id": "source:pmid:29681787", "type": "manuscript", "label": "PMID 29681787 full text"}, {"id": "data:geo:PXD008440", "type": "dataset", "label": "GEO PXD008440"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-29681787", "type": "extraction", "used": ["source:pmid:29681787"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD008440", "type": "accession_resolution", "used": ["data:geo:PXD008440"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:29681787", "parent_hash": "sha256:b2ff0fd46bd727ca4c5b476eb7f10e25795e2009efa80bd21c72c17105d872ea", "fork_of": null, "generation": 7}, "gaps": ["asset:data:geo:PXD008440 licence not read", "asset:data:geo:PXD008440 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "microarray", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["tial responders, RT radiotherapy, TMA tissue microarray, TR total responders Table 1Baseline patient", "the paraffin blocks (Fig. 2b) using a Tissue Microarray (TMA) Master II (3DHISTECH) (Fig. 1b).Fig. 2", "formalin-fixed paraffin-embedded, TMA tissue microarray Statistical analysis The different groups of"], "order_basis": "paper_text_order:6711", "id": "assay:1"}, {"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Finally, the analysis of mass spectrometry data were next carried out with the Perseus software package [19] and subjected to a normalization (z-score) and an ANOVA statistical test (comparison of the three groups) or Student’s T test (comparison of two groups), both corrected with a p value of 0.05."], "order_basis": "consumes_earlier_output", "id": "assay:2"}]}